THOMAS VANCE: Open Payments
NPI 1649654385 · SWEETWATER, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,612 in 151 payments from 31 companies in 2025. Trend: 2023 $2,179 · 2024 $3,077 · 2025 $2,612
Food & beverage: $2,487Speaker / faculty: $75Long term medical supply or device loan: $50
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 44 | $602 |
| PFIZER INC. | 18 | $227 |
| Novartis Pharmaceuticals Corporation | 10 | $196 |
| Aimmune Therapeutics, Inc. | 7 | $167 |
| Abbott Laboratories | 7 | $145 |
| Lundbeck LLC | 5 | $109 |
| Madrigal Pharmaceuticals | 5 | $98 |
| Janssen Biotech, Inc. | 6 | $98 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $88 |
| Novo Nordisk Inc | 4 | $81 |
Products named: ZENPEP, RINVOQ, LEQVIO, MAVYRET, NURTEC ODT, ELIQUIS, VYEPTI, CREON.
Industry payments across TN — which companies pay providers there.
